Search the Newsreel

Haemonetics earnings up next as estimates cool ahead of print

Haemonetics Corporation is set to report its first-quarter fiscal 2027 results, with analysts expecting a sequential decline in earnings and revenue. Investors will be focused on explanations for the anticipated revenue drop, margin sustainability, and updates on growth catalysts like recent FDA approvals. Despite …

Weyerhaeuser (WY) Receives a Buy from Citi

Citi analyst Anthony Pettinari maintained a Buy rating for Weyerhaeuser (WY) with a price target of $29.00, citing his 5-star analyst status and strong track record. This positive outlook follows Weyerhaeuser's Q2 earnings, where the company reported a significant increase in net profit to …

Schaeffler steigert Ergebnis und will mehr sparen - Aktie gefragt

Schaeffler India Shares Rise Over 2% in Midday Trade

What To Expect From Haemonetics’s (HAE) Q2 Earnings

Schaeffler steigert operativen Gewinn wie erwartet - Jahresprognose steht - 05.08.26 - News

Haemonetics (HAE) Is Up 5.1% After New VASCADE MVP XL Real-World Study Data Release – Has The Bull Case Changed?

Haemonetics (HAE) saw its stock rise by 5.1% following the release of new real-world study data for its VASCADE MVP XL venous vascular closure system. The study from Emory University indicated rapid hemostasis, high same-day discharge rates, and low complication rates for the device. …

Can New VASCADE MVP XL Data Strengthen Haemonetics' (HAE) Moat in Electrophysiology Adjacent Markets?

Haemonetics (HAE) recently published data from a large Emory University study showing its VASCADE MVP XL venous vascular closure system achieved rapid hemostasis and low complication rates in electrophysiology procedures. This real-world evidence, following an FDA label expansion, strengthens the clinical case for VASCADE …

Weyerhaeuser Co. stock outperforms competitors on strong trading day

Weyerhaeuser Co. (WY) stock rose 2.38% to $25.83 on Tuesday, outperforming the broader market. This marked the third consecutive day of gains for the company, as the S&P 500 Index and Dow Jones Industrial Average also saw increases.

Goforth to retire after 50 years at Weyerhaeuser

Jerry Goforth is retiring from Weyerhaeuser after 50 years, having started at the Philadelphia mill at age 21. Throughout his career, he worked in various roles, became a saw filing manager, and significantly contributed to the evolution of safety practices at the mill. Goforth …

Weyerhaeuser Q2 profit climbs with improved timberland sales

Weyerhaeuser reported a significant increase in Q2 net earnings to $162 million, up from $87 million in the same period last year, driven by improved timberland sales and divestitures. The company's adjusted EBITDA was $310 million, and it anticipates slightly higher earnings in Q3 …

Haemonetics study shows VASCADE MVP XL posts 1.2% vascular complications in 1,623 large-bore electrophysiology cases

A new retrospective study on Haemonetics' VASCADE MVP XL device, published by Public Technologies (PUBT) and sourced from PR Newswire, demonstrates a low 1.2% vascular complication rate in 1,623 large-bore electrophysiology procedures. The study highlights the device's efficacy in fast vessel closure, support for …

Weyerhaeuser Company (WY) Stock Price | Live Quotes & Charts | NYSE

This page provides live stock quotes and charts for Weyerhaeuser Company (WY) on the NYSE, showing its current price and daily change. It also includes sections for analyst ratings and earnings information, although specific data for WY's ratings and earnings is currently unavailable. The …

Haemonetics study shows safety data for vascular closure device

Haemonetics Corporation announced the publication of a study demonstrating the safety and effectiveness of its VASCADE MVP XL venous vascular closure system. The study, funded by Haemonetics and conducted at Emory University, involved 1,623 patients undergoing large-bore venous access electrophysiology procedures, showing a low …

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

BOSTON, Aug. 3, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced publication of a study providing new evidence supporting the safety and efficacy of Haemonetics' VASCADE MVP® XL …

Haemonetics stock hits 52-week high at 87.49 USD By Investing.com

Haemonetics (HAE) stock has reached a new 52-week high of $87.49, reflecting strong investor confidence and positive market sentiment. The stock is currently trading just below its peak, showing an 81% increase from its 52-week low and a 14.4% positive return over the past …

Truist raises Weyerhaeuser stock price target on earnings beat By Investing.com

Truist Securities has increased its price target for Weyerhaeuser (NYSE:WY) shares from $27 to $28, maintaining a Hold rating, following the company's Q2 operating earnings per share of $0.13, which surpassed analyst estimates. Despite the stock appearing overvalued relative to its Fair Value according …

Weyerhaeuser Puts Data Centre Land at a Premium to Standing Timber

Weyerhaeuser, the largest private timberland owner in the US, reported a strong quarter with $310 million in adjusted EBITDA. The company is strategically marketing land for data center development, which commands significantly higher prices than timber values. Weyerhaeuser is also advocating for data centers …

Weyerhaeuser (WY) Stock Rallies As Valuation Doubts Follow One Off Gain

Weyerhaeuser (WY) stock recently jumped 6.5%, though its high trailing P/E of 45.5x contrasts with analysts' discounted cash flow valuations. The Q2 2026 earnings showed a mix of asset strength in Timberlands and Strategic Land Solutions, partly offset by cyclical Wood Products revenue and …

Haemonetics Number of Employees 2026 | Employee Count & Headcount Data

Haemonetics Corp. (HAE) had approximately 3,017 employees worldwide as of March 2026, representing a 2.7% decline since 2023. Despite this decrease, the company is actively hiring, with 259 active job postings in 2026, a 56.4% increase from 2025. The workforce is primarily concentrated in …

InvestingPro Fair Value nails 64% return on Haemonetics stock By Investing.com

InvestingPro's Fair Value models successfully identified Haemonetics Corporation (NYSE:HAE) as significantly undervalued in October 2025, leading to a 64% return for investors who acted on the analysis. The stock surged from $50.26 to $85.54 within nine months, validating the intrinsic value assessment. This case …

Weyerhaeuser Q2 Earnings Call Highlights

Weyerhaeuser (WY) reported solid second-quarter 2026 GAAP earnings of $0.23 per diluted share on net sales of $1.9 billion, driven by stronger lumber prices despite challenging market conditions. The company's Wood Products segment saw gains from increased lumber pricing and sales volumes, while Timberlands …

Haemonetics (HAE) Appoints Martin Madaus To Its Board With Diagnostics Experience

Haemonetics Corporation (NYSE:HAE) has appointed Dr. Martin Madaus to its Board of Directors, bringing extensive experience from leadership roles in diagnostics and life sciences. This appointment is part of ongoing Board refresh efforts and aims to sharpen the company's focus in product development, M&A, …

Weyerhaeuser Reports Second Quarter Results

Weyerhaeuser reported net earnings of $162 million, or $0.23 per diluted share, for the second quarter of 2026, with Adjusted EBITDA reaching $310 million. The company completed the divestiture of non-core timberlands in Oregon and advanced its growth initiatives. Despite macroeconomic uncertainty, Weyerhaeuser is …

Weyerhaeuser Co Q2 2026: Revenue $1.87B, EPS $0.23— 10-Q Summary

Weyerhaeuser Co (WY) reported its Q2 2026 financial results with revenue nearly flat year-over-year at $1.87 billion, while net income significantly increased to $162 million due to timberland sales and a tax benefit. Diluted EPS rose to $0.23 from $0.12 in the prior year. …

Weyerhaeuser raises 2026 Strategic Land Solutions adjusted EBITDA guidance to about $450M while targeting Monticello start-up in H1 2027

Earnings Call Insights: Weyerhaeuser (WY) Q2 2026 MANAGEMENT VIEW * "Yesterday, Weyerhaeuser reported second quarter GAAP earnings of $162 million or $0.23 per diluted share on net sales of $1.9 billion." (President, CEO & Director Devin Stockfish) * "Excluding a special item, we earned …

Weyerhaeuser Q2 Earnings & Sales Top, Adjusted EBITDA Down Y/Y

Weyerhaeuser (WY) reported better-than-expected Q2 2026 financial results with adjusted earnings and net sales surpassing Zacks Consensus Estimates, though adjusted EBITDA decreased year-over-year. The company's Wood Products segment rebounded, while Timberlands results remained resilient despite a decline in adjusted EBITDA. Strategic Land Solutions saw …

Earnings call transcript: Weyerhaeuser tops Q2 2026 estimates as shares rise 4.4%

Weyerhaeuser reported strong Q2 2026 results, surpassing Wall Street expectations with adjusted earnings of $0.13 per share and revenue of $1.87 billion, driven by robust lumber pricing and wood product performance. The company’s shares rose 4.4% in after-hours trading. Despite macroeconomic challenges, Weyerhaeuser's management …

Weyerhaeuser (WY) Beat Expectations, Is The Stock Still Below Fair Value?

Weyerhaeuser (WY) surpassed Wall Street's revenue and EPS expectations in Q2 2026, reporting net income of US$162 million and EPS of US$0.23. Despite positive earnings, the stock price has eased, with a 3.9% decline in the last day and a 1.3% year-to-date slip. The …

Weyerhaeuser Company 2026 Q2 - Results - Earnings Call Presentation (NYSE:WY) 2026-07-31

What Is Putting Michael Hill (ASX:MHJ) in Focus?

Weyerhaeuser Rallies After Q2 Earnings Beat and Stronger Wood Products Trends

Compared to Estimates, Weyerhaeuser (WY) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Weyerhaeuser (WY) reported revenue of $1.87 billion, down 0.9% over the same period last year. EPS came in at $0.13, compared to $0.12 in the year-ago quarter. The reported revenue represents a surprise of +4.03% over the Zacks …

Weyerhaeuser lumber realizations rise 15% from Q1 as volumes increase

Weyerhaeuser reported second-quarter net earnings of $162 million, up from $87 million a year earlier, with lumber sales realizations rising 15% to $508 per thousand board feet as volumes increased. The company's Wood Products Adjusted EBITDA grew by $58 million to $129 million, although …

Weyerhaeuser Profit Rises, As Lumber and Western Log Prices Increase

Weyerhaeuser reported an increase in profit, driven by higher lumber and western log prices. The company's performance was positively impacted by market conditions for wood products. This financial uplift demonstrates the company's strong position in the timber and wood products industry.

Weyerhaeuser Co Announces Climb In Q2 Profit

(RTTNews) - Weyerhaeuser Co (WY) revealed a profit for its second quarter that Increases, from the same period last year The company's bottom line came in at $162 million, or $0.23 per share. This compares with $87 million, or $0.12 per share, last year. …